End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.015 USD | -3.33% | -6.02% | -8.56% |
Quotes 5-day view
End-of-day quote Nasdaq2024-05-16 | 2024-05-17 | 2024-05-20 | 2024-05-21 | 2024-05-22 | |
---|---|---|---|---|---|
Last | 1.05 $ | 1.015 $ | 1.0499 $ | 1.05 $ | 1.015 $ |
Volume | 17 295 | 24 574 | 10 158 | 6 648 | 5 251 |
Change | -2.78% | -3.33% | +3.44% | +0.01% | -3.33% |
Opening | 1.07 | 1.00 | 0.98 | 1.04 | 0.98 |
High | 1.08 | 1.12 | 1.05 | 1.05 | 1.04 |
Low | 1.00 | 0.86 | 0.98 | 0.98 | 0.98 |
Performance
1 day | -3.33% | ||
1 week | -6.02% | ||
Current month | -3.32% | ||
1 month | -4.69% | ||
3 months | +0.50% | ||
6 months | -28.01% | ||
Current year | -8.56% | ||
1 year | -90.71% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Bio Therapeutic Drugs
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-3.33% | -6.02% | -8.56% | -90.71% | 37.16M | ||
+1.25% | +2.29% | +9.99% | +31.64% | 115B | ||
-1.02% | +0.57% | +12.01% | +30.91% | 106B | ||
+11.11% | +10.95% | -3.07% | -4.84% | 24.69B | ||
0.00% | -1.07% | -0.67% | -12.06% | 21.97B | ||
+0.10% | +1.63% | -4.45% | -28.88% | 19.27B | ||
+0.32% | +1.84% | -6.90% | -30.63% | 17.56B | ||
+0.94% | -2.43% | -39.36% | -35.50% | 17.32B | ||
-0.80% | -1.81% | +5.82% | +49.12% | 14.03B | ||
-0.64% | -3.17% | +33.05% | -13.93% | 12.13B | ||
-0.84% | -6.91% | -29.20% | -38.23% | 7.77B | ||
-3.11% | -0.38% | +13.63% | +44.22% | 7.76B | ||
-0.29% | -1.56% | -1.77% | +22.50% | 7.59B | ||
+6.75% | +5.72% | +4.12% | +45.47% | 7.52B | ||
-2.13% | -11.54% | -56.49% | -71.28% | 7.01B | ||
-1.90% | -19.23% | +238.58% | +158.77% | 6.95B | ||
Average | -0.04% | -1.82% | +10.42% | +3.54% | ||
Weighted average by Cap. | +0.35% | +0.64% | +7.86% | +16.58% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | -8.56% | ||
2023 | -89.21% | ||
2022 | +3.83% | ||
2021 | +1.64% |
- Stock Market
- Equities
- ESLA Stock
- Quotes Estrella Immunopharma, Inc.